Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Sana Biotechnology, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 123 | 136 | +13 |
| Shares | 134.9M | 127.5M | −7.43M (−5.5%) |
| Value | $804.1M | $493.5M | −$310.7M (−38.6%) |
New holders (23)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (10)
Institutions that held Sana Biotechnology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Artal Group S.A. | 400,000 | $2.38M |
| Occudo Quantitative Strategies LP | 129,204 | $770.1K |
| Franklin Resources Inc | 44,112 | $262.9K |
| Advisory Research Inc | 19,806 | $118.0K |
| Virginia Retirement Systems Et Al | 14,000 | $83.4K |
| Aigen Investment Management, LP | 13,171 | $78.5K |
| Sherbrooke Park Advisers LLC | 12,800 | $76.3K |
| XTX Topco Ltd | 10,081 | $60.1K |
| The PNC Financial Services Group, Inc. | 600 | $3.58K |
| Allworth Financial LP | 33 | $197 |